OTUD5

OTU deubiquitinase 5, the group of OTU domain containing

Basic information

Region (hg38): X:48922024-48958386

Links

ENSG00000068308NCBI:55593OMIM:300713HGNC:25402Uniprot:Q96G74AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • multiple congenital anomalies/dysmorphic syndrome (Moderate), mode of inheritance: XL
  • multiple congenital anomalies-neurodevelopmental syndrome, X-linked (Strong), mode of inheritance: XL

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Multiple congenital anomalies-neurodevelopmental syndrome, X-linkedXLCardiovascularThe condition can involve congenital cardiac anomalies, and awareness may allow early managementCardiovascular; Craniofacial; Genitourinary; Musculoskeletal; Neurologic; Renal33131077; 33523931

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the OTUD5 gene.

  • Multiple congenital anomalies-neurodevelopmental syndrome, X-linked (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the OTUD5 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
4
clinvar
1
clinvar
5
missense
1
clinvar
1
clinvar
34
clinvar
36
nonsense
0
start loss
0
frameshift
1
clinvar
1
inframe indel
2
clinvar
2
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 1 1 37 4 1

Variants in OTUD5

This is a list of pathogenic ClinVar variants found in the OTUD5 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
X-48923186-T-C Likely benign (Apr 01, 2022)2660489
X-48923188-G-T Ependymoma Uncertain significance (Dec 29, 2017)487794
X-48923659-A-AT Inborn genetic diseases Uncertain significance (Jun 20, 2024)2231015
X-48923669-G-A Multiple congenital anomalies-neurodevelopmental syndrome, X-linked • Inborn genetic diseases Conflicting classifications of pathogenicity (Feb 23, 2023)2204087
X-48923681-C-T See cases Uncertain significance (Sep 14, 2021)1690437
X-48923701-G-A Multiple congenital anomalies-neurodevelopmental syndrome, X-linked Uncertain significance (Nov 20, 2023)1710154
X-48923735-G-A Multiple congenital anomalies-neurodevelopmental syndrome, X-linked Pathogenic (Apr 22, 2021)1174501
X-48923851-C-T Multiple congenital anomalies-neurodevelopmental syndrome, X-linked Pathogenic (Apr 06, 2021)996323
X-48923856-G-A Uncertain significance (Jul 31, 2022)2428947
X-48923877-G-C Inborn genetic diseases Uncertain significance (Dec 29, 2021)2409019
X-48923887-A-T Abnormal cerebral cortex morphology;Dysplastic corpus callosum Uncertain significance (May 12, 2021)1077146
X-48923913-A-G Inborn genetic diseases Uncertain significance (Dec 09, 2023)3207387
X-48923941-G-T Multiple congenital anomalies-neurodevelopmental syndrome, X-linked Uncertain significance (Sep 30, 2022)2434529
X-48923964-C-G Uncertain significance (Dec 09, 2022)2504722
X-48923973-G-A Uncertain significance (Feb 03, 2023)2574968
X-48925870-G-A Inborn genetic diseases Uncertain significance (Sep 14, 2021)2217476
X-48925888-C-A Uncertain significance (Jul 25, 2022)1940240
X-48925907-G-C Benign (Feb 16, 2018)774751
X-48925915-G-A Multiple congenital anomalies-neurodevelopmental syndrome, X-linked Pathogenic (Feb 09, 2021)996326
X-48925925-C-T Likely benign (Nov 01, 2022)2660490
X-48925989-T-C Multiple congenital anomalies-neurodevelopmental syndrome, X-linked Uncertain significance (Jun 07, 2022)3066319
X-48926010-G-A OTUD5-related disorder Likely pathogenic (Feb 28, 2023)2629974
X-48926014-T-G OTUD5-related disorder Uncertain significance (Jan 17, 2024)2632827
X-48930032-AGGTGGAGCTTGCTGTGAGCCGAGATCACGCCACTGCACTCCAGCCTGGGCGACAGAGCGAGACTCTGTCTCAAAAAATAATAATAATAAAATAAAATAAAAATAAACACCCTCATTTGAAGGGGGTGGGGGTACAAGTAGGTCACTTTCAAAATGAATGGAGTCTGTAACACCAAAGGCAAAAAAGAACTATATGTAGCATTGAGCTATAGTGATAAAGTTGTTTCCCACGGGGGTACGGGTGAACAAGTGTGATTCTGCTACGCGTGTATATGGAAATGAGCAGTTACATAAATGGATGGTAGGAACCAGTGCATATACATCTGATGGCGTATCTACTGTTGGAGAGGGAATTTGCAGATGAACAAGGGGAGAAGGCTAGAATGAAGCATGTGATAATGGATCTGAGTTGGAGACATCAGTAAGGATTCATGTTTAATATAAATACAGATGGTTACAGGTAGAAATATTTATAGATATGTGTACAAAGGCCACTATACATACATGTAGCTCCTTGCTCTATCAGCTGACAGGGCCTAGAAGCATGGACAACCTGATATCGAAGAGCACATTCAACACCTAGGTCTTGATTTCTGTTAACAGTCTCCAATACATGCCAGGGCTCTCTAAAGAAATGGCTGATTGAGCTGGGCGCAGTAGCTCACACCTGTAATCCCTGCACTTTGGGAGACCGAGGAGGGTGGATCACCTGAGGTCAGGAGTTCGAGACTTCAGCCTGCCCAACATGGTGAAACCCCATCTCTACTAAACAATACAAAAAACAGCTGGGTGTGGTGGCGCATGCCTGTAATCCCAGCTACTCGGGAGGCTGAGGCAGGAGAATCGCTTGAACCTGGGAGGCAGAGGTTGCAGTGAGCTGAGATGGCGCCCTTACACTCCAGCCTGGGCAACAAGAGCGAAACTCCCTCTCAAAAAAAAAAAAAAGACCATATTGATGTACGTAATAACTGGAAAAATTAATAAATTAAGGATGAGTTAAGGATGAGACACAGATCCTCCTTAAAGATTTCCAAATAATCTATGTAGATACTCTACCCTCAAGGGGATGGGGCATAACCATTTCTTAGGCGTGGGCTGCACATAGTGACTTCCTTCCACACAGTACAGTATGGAAAAGGTGGGAAAGAGTAACCTTAGGTGGAGAAACCTAACAAACACTACTTCTGCCAGTTGATCAAGGGTAACACCAACAGGCATAAATGACACTCATAGTATAAACCCTTGAAATGATGTAATGACAATGGCACTTTACCTCTGTGATCTTCCTCCCTAAGACCCACAACCCTAGTTTAAACATGAGAAAAAGTCCAAAAGAGACATTTCCTACAAAATATTTGATCAGTACTCCTTAAAACTGTCAAGGTCATCAAAACAAAACTGAGAAACTATCAAAGATAAAGGGGCCTAAGGAGGCATGCAGATTTCATTTAATAGTAACGTATTAGGCTGGGCATGGTGGCTCACGCCTGTAATCCCAGCACTTTGGGAGGCCGAGGCGGGTGGATCACCTGAGGTCAGGAGTTTGAGACCAGCGTGGCCAACATGGTGAAACCCCGTCTCTACTAAAAATAGAAAAATTAGCCAGGTGTGGTGGTGGGCACCTGTAATCCCAGCTACTTGGGAGGCTGAGGCAGAAAAATCGCTTGAACCCAGAAGGCGGAGGCTGCAGTGAGCCGAGATCGCCTCATTGCACTCCAGCCTGGGTAACAGAGAGAAACTCTGCCTTAAAAAAAAAAAAAAAAAAAGTATTAATGTTGGTTCGCACATTGTAACAAATGTACCATAATGATTTGAACTGTTAATAACAGCAGAACTGGGCTGGGCGCGTTGGCTCACGCCTGTAATCCCAGCATTTTGGGAGGCCGAGATGGGTGGATCACCTGAGGTCAGGAGTTCGAGACCAGCCTTTGACATGGTGAAACCCCGTCTCTACTAAAAACACAAAAATTAGCTGGGCGTGGTGGCGGGTGCCTGTAATCCCAGCTACTCGGGAGGCTGAGGCAAGAGAATTGCTTGAACCCGGGAGGCAGAGGTTGCAGTGAGCCAAGATTGCGCCATTGCACTCCAGCCTGGGTGATGAGAGAGAAACTTCGTCTCAAAAAAAAGATGATAATAATAATAATAATAATAATAATAATAATAATAATAATAGCAGAACTGTGTTTGGGAAGAGAAGGATATGTGGGAATTCTGTATTATCTCCTCAATTGTTCTGTAAATCTAAAACTGCTCTAAACAATTAAGTCTATTAAATACAAAAACTTAAAACATTCATTTTTATTTTTTCTTTCAGACAGAGTCTCGCTCCGTCACCCAGGCTGCAGTGCAGGGGTCAAATCTCAGCTCACTGCAACCTCTGCCTCCTAGGTTCAAGTGATTCTCCTGCCTCGGCCTCCCAAGTAGCTCGGATTACAGGTGTGTGCCACCACACCCGGCTAATTTTTTTTTGTATTTTTAGTAGAAACAGGGTTTCATCATGTTGGCCAGGCTGGTCTCGAACTCCTGACCTCAGGAGATCCTCCCATCTCAGCCTCCCAGTGTTGGGATTACAGGCGTGAGCCACCGCACCTGGCCAGAACATTCATATTTTTGAAGAAAGAAAAAGAGGAAGCTGGGTGCAGTGGCTCATGCCTGTAATTCCAGCACTTTGGGAGGCCGAGGCACAAGGATCACTTGAGCCCAAGAGTTCAAGGTCAGCCTCGGCAATATAGTGAGACCTTGTCTCTACAAAAAAAAAAAATTTTTTTTCATTTTTTTACAAAAAGTTTTTTTAAAACACTGGCCGGGCATGGTGGCGAGCACCTGTAGTCTCCCAGCTACTCGGGAGGCTGAGGTGAGAGGCTTGCTTGAGCCAGGGAAGTGGAGGCTAGCTACAGTGAGCCTAGATTGCCCCACTGCACTCCAGCCTGGGTGAGAGAGTGAGACCCTGTCTCTCCACCCGCCCACCAAAAAAGAAAATGAGCCATTAAACCAGGACAAGTCACAGATGAATCTTAAATGCATAGTGTTAAGTGAAAAAAGCCAGTCTGAAAAAGCTACATACTGTACATTTCCAATTATATGACATTCTAGAAAAGGCAAAACGAGAGTCAGTAAACAGATCGAATACAAAAAACAAGAAAATTCTGAGAAACTGTCACAGCCAAGAGGAGATAAAGGGGACACAACAACTAAATATAATATGGCACCCTGGATGGGATCCTGGAACAGATAAAGGTCATTAGGGAAAAACTAAGGTAATCTGAGTCAAGTATGGTCTTTAGTTAATAATATGTCGATATTGGCTCATTAACTATGACAAATGTACTATGTTAATACATTAATCATAGCGAGGCATATGGGAACTCTGTAATATATTTGTAACTTTTTTTTTTTTTTTTTGAGACAGAGTCTCATTCTGTCGCCCAAGCTGGAGTGCAGTGGCACAATCTTGGCTCACTGCAACCTCTGCCTCCCAGTTTCAAGTGATTCTCCTGCCTCAGCCTCCCAAGAGTAGTTGGGATTACAGGCACCCACTGCCACACCCAGCTAATTTTTGTATTTTTAGTAGAGACAGGGTTTCACCATGTTAGCCAGGCTGGTCTTGAACCCCTGACCTCAGGTGATCTGCCAGCCTCGGCTTCCCAAAATGCTGGGATTACAGGTGTGGGCCACCGTGCCCAGCCTCTTTGCAGTAATTCTGTAAATCTAAACCTGCTCTAAAATTAAGTTTATTTAAAAACAAAACAAAAAAGAACCCTATGTTGGAGGGTGTGTTGGTGTTAGGCTATGTGTTTCCGAAAATGAAGCAGGAGTACTTTGTGTTTGTAGAAGTGAAACCTGAATAGAAGATACCAAAATCCTCAGCAAATGACTGTAAGAGAGAGAGAGAGAAATGAATGAGAATCTATCGGTATGTGCTGGGAAAATGCACTGCCACCTTCTGAACACCTACTAGGCCCCAGGCCCAGTGGGAGGTGCTTTCTGTATCAGCCAAGCTGCCAGCCTGGAATACTTACAGAATCTGCCTAGATCACACAGCCAGTGAGTGGTGGGGCCAGGCCTGTACCCCATGTCTCTGTGACCATGGCTGTCTGTAACCACTATGATCCCAGGAGAAAGATCCATGCCAAGATGCCCAGAGCAAGCCCTGGCTCACTGCTCCAAAATAGGACTCCACATCCTAAAATGCCAGCCCTCAACGGGCACAAAAGATAGGTAAGCCAACTCAGACAGGCAAACCAAGACCAAAGAACAAGCCCTGAGAGATCACCTTAAGTAACTCCCTATTTTTTTTTTTTTTTTTGTAAGGGTGAGACCTCAGGGGAGAGAGGAGACAGGATATTTTTGTGAGTTAGGGGCAAAACAGACTCCAACAGAGGTTTCTGACCTCTATATCCAGCAGCCATTCTGGGCACAGGGACCCACTCACCCCTGGTTTGAATGATGGCAGGCCCAGCCCCACACCAATGGTGGCCTTGTTAGGATTCACCACTGAATTATAGTGGATATTCCGATGGTAGCTAACACGAATGGGTTCGTCCTCGTTTTGATGTATCCCATGGAATGTGTTGATGGGTTCTGCAGAGAAAGAGAAGGAGGGAGCATCCACAGCAGGCCAGGTTGGGCAGGCTCGAATGAGGCACCATCTTTCCCTCACCTACCCACTGCAGAAGTACCTGTGCTGTACTGGTACACCTCCACAGGACGGTTGTACATCTCTGCCATGGCCTGCATCTCAATGTGGTTGCCATGGCAATTGTTTTTCCGCTTCCTGTTAATGTAGGTGGTAAAGTCCTCTGTGACATAGTTGGAGAAGTAGTCGGCATTCTTCATCTGCAGAATAGATTGGAAGGTTAAGGTCTGTGTGGAGAAGAAATCCTCCCACCCTGCCCCTTCCCCAAAGGCCTCCATTTTCTCACCAGATAGTCCATGCAATGCTTTCGCACAACCTCATGCATGTCCTGGTCTCCATACACCTGGTCAGCTGTGGGGGCAGAAGAAAGCAGCAGCTAGGGTCAGAGATGCCAGAGAAGAGCTCTGAATCATAGAACATCCTTTGGGGAGGAGGAACTGGGGGACCAGGGAAATTCCCTTTTCTACCCCAAGGCCTGGAGAGTTCTTGCCCTTGTAGGCTAGAACGGGGTCATGGAAAAATATGGCAGGCAGGGCCAGACTTGAAGAACAAGAGAGTGCAGGTGAGAGGAACACATCCACAGGCCTCTTGGGCAGATGACTTTGTCTAGGGTACACGTGGCCACTCAGAGAAATCAACAACATTCTAAGTTCCACAGGTTGGCCTCAAATGCTATTGATTCCCACACCCCCTTTGCTTTCCACATGAGGAAACTGAGGTTCAGGGGGAGTTTGTGGTTTGTCCAAGGTCACAAAGAGTCAGTCTGTGACAGAGTCAACTCTGAATTCAGTTTTCCTGACTCCTACAAGTCAACATGGCCTTTGTAGGCTGAAAAAAAAGGGAACAAAGACAAAAAAAGGAAAGAAAAAAAAATGGGCTCCAAGCCCAGTTCTGCCAGATACTAGAGAGTTGAGTGACCAGAGGCAAGTGACCCAAGTGTTCTGAGCCTCATATACCTCATCTGTAAAATGGGAAAAAGAGGGATAACAGGCCAGGCGTGGAGGCTCACACCTGTTATCCCAGCACTTTGGGAGGCCAAGGTGGGCAGATCACTTGAGGTCACGAGTTCGAGACCAGCCTGGCCAACGTGGTAAAACCCCGTCTCTACCAAAAATACAAAAATTAGCCGGGCATGGTGGCGGGCGCCTATAATCCCAGCTACTTGGGAGGCTGAAGCAGGAGAATCGCTT-A Neurodegeneration with brain iron accumulation 5 Likely pathogenic (Jun 19, 2019)635108
X-48934483-A-G Multiple congenital anomalies-neurodevelopmental syndrome, X-linked Pathogenic (Aug 06, 2021)996324

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
OTUD5protein_codingprotein_codingENST00000156084 936344
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.9970.0028300000.00
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense3.99442050.2150.00001643643
Missense in Polyphen360.5170.049573961
Synonymous0.05427979.60.9920.000006241188
Loss of Function3.85017.20.000.00000132262

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.000.00
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Deubiquitinating enzyme that functions as negative regulator of the innate immune system. Acts via TRAF3 deubiquitination and subsequent suppression of type I interferon (IFN) production. Has peptidase activity towards 'Lys-48'- and 'Lys-63'-linked polyubiquitin chains. Can also cleave 'Lys-11'- linked ubiquitin chains (in vitro). {ECO:0000269|PubMed:17991829, ECO:0000269|PubMed:22245969, ECO:0000269|PubMed:23827681}.;
Pathway
RIG-I-like receptor signaling pathway - Homo sapiens (human);Regulation of toll-like receptor signaling pathway;Gastric Cancer Network 2;RIG-I-like Receptor Signaling;Post-translational protein modification;DDX58/IFIH1-mediated induction of interferon-alpha/beta;Metabolism of proteins;Innate Immune System;Immune System;Negative regulators of DDX58/IFIH1 signaling;Ovarian tumor domain proteases;Deubiquitination (Consensus)

Recessive Scores

pRec
0.105

Intolerance Scores

loftool
rvis_EVS
-0.16
rvis_percentile_EVS
41.25

Haploinsufficiency Scores

pHI
0.368
hipred
Y
hipred_score
0.831
ghis
0.513

Essentials

essential_gene_CRISPR
E
essential_gene_CRISPR2
S
essential_gene_gene_trap
K
gene_indispensability_pred
E
gene_indispensability_score
0.772

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Otud5
Phenotype
homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; digestive/alimentary phenotype; immune system phenotype; embryo phenotype;

Zebrafish Information Network

Gene name
otud5b
Affected structure
trunk
Phenotype tag
abnormal
Phenotype quality
bent

Gene ontology

Biological process
protein deubiquitination;negative regulation of type I interferon production;response to lipopolysaccharide;protein K63-linked deubiquitination;protein K48-linked deubiquitination
Cellular component
cytosol
Molecular function
thiol-dependent ubiquitin-specific protease activity;Lys63-specific deubiquitinase activity;ubiquitinyl hydrolase activity;Lys48-specific deubiquitinase activity